Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.88 |
| ▸ | EYA2 | O00167 | 1/20 | 0.88 |
| ▸ | APP | P05067 | 1/20 | 0.88 |
| ▸ | ACE | P12821 | 1/20 | 0.88 |
| ▸ | BLM | P54132 | 2/20 | 0.82 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.82 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.82 |
| ▸ | TSHR | P16473 | 2/20 | 0.82 |
| ▸ | LMNA | P02545 | 1/20 | 0.82 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.82 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.82 |
| ▸ | DRD1 | P21728 | 1/20 | 0.82 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.82 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.82 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.82 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.82 |
| ▸ | DRD3 | P35462 | 1/20 | 0.82 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.82 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edetic Acid SCHEMBL42175 | 1.00 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL1566615 | 1.00 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL531145 | 1.00 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL769944 | 1.00 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL121502 | 1.00 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL531146 | 1.00 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Pentetic Acid SCHEMBL2819134 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL2327395 | 0.97 | TDP1 (0.82) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL8331922 | 0.97 | TDP1 (0.82) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL5571235 | 0.97 | TDP1 (0.82) | TDP1EYA2APPACEBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230099362-A1 | LIQUID VEHICLE FOR ENTEROGRAPHY EXAMINATION | QUAGLIANO PETER (US) | 2023-03-30 | — | — | US | claimed |
| CN-111249200-A | Powder for fixing makeup and preparation method and application thereof | 伽蓝（集团）股份有限公司 | 2020-06-09 | — | — | CN | claimed |
| CN-106170582-A | Pharmaceutical packaging SiO < x > barriers and coating method | SIO2医药产品公司 | 2016-11-30 | — | — | CN | claimed |
| EP-3049123-A1 | CATHETER LOCKING FORMULATION AND METHOD TO PREPARE SAME | Appelt, Krzysztof (US) | 2016-08-03 | — | — | EP | claimed |
| WO-2015191686-A1 | METHODS OF ADMINISTERING METHYLNALTREXONE | SALIX PHARMACEUTICALS, INC. (US) | 2015-12-17 | — | — | WO | claimed |
| WO-2015048559-A1 | CATHETER LOCKING FORMULATION AND METHOD TO PREPARE SAME | APPELT KRZYSZTOF (US) | 2015-04-02 | — | — | WO | claimed |
| CN-103930595-A | Passivation, ph protective or lubricity coating for pharmaceutical package, coating process and apparatus | SIO2 MEDICAL PRODUCTS INC | 2014-07-16 | — | — | CN | claimed |
| CN-103211760-A | Clevidipine butyrate intralipid and preparation method thereof | SHANGHAI CDYMAX PHARMACEUTICALS CO LTD | 2013-07-24 | — | — | CN | claimed |
| CN-101405031-B | Formulations for parenteral delivery of compounds and uses thereof | WYETH CORP | 2012-10-10 | — | — | CN | claimed |
| CN-102695413-A | Stable fatty acid formulations | MYCELL HOLDINGS LTD | 2012-09-26 | — | — | CN | claimed |
| CN-1753683-A | Ophthalmic formulation for the prevention and treatment of ocular conditions | CHAKSHU RES INC (US) | 2006-03-29 | — | — | CN | claimed |
| CN-1230099-C | Beverage products having superior vitamin stability | PROCTER & GAMBLE (US) | 2005-12-07 | — | — | CN | claimed |
| CN-1672530-A | Method for preserving fruits vegetables and mushrooms | GIORGIO FOODS INC (US) | 2005-09-28 | — | — | CN | claimed |
| WO-2005070393-A2 | DIRECTLY COMPRESSIBLE PHARMACEUTICAL COMPOSITION OF THE RAPAMYCIN ESTER CCI-779 | WYETH (US) | 2005-08-04 | — | — | WO | claimed |
| US-20050152983-A1 | Directly compressible pharmaceutical composition for the oral administration of CCI-779 | WYETH (US) | 2005-07-14 | — | — | US | claimed |
| CN-1406124-A | Nasal administration of cyclic peptide compositions | BASILEA PHARMACUEITCA AG (CH) | 2003-03-26 | — | — | CN | claimed |
| CN-1402747-A | Chelating agent salts as polymerization catalysts for polycarbonates | GEN ELECTRIC (US) | 2003-03-12 | — | — | CN | claimed |
| CN-1354626-A | beverage with excellent vitamin stability | PROCTER & GAMBLE (US) | 2002-06-19 | — | — | CN | claimed |
| CN-1069825-C | Demethyl coclanrine water injection for coronary heart disease diagnosis | FUWAI ANGIOCARDIOPATHY HOSPITA (CN) | 2001-08-22 | — | — | CN | claimed |
| CN-1178704-A | Demethyl coclanrine water injection for coronary heart disease diagnosis | NUCLEAR MEDICINE DEPART FUWAI (CN) | 1998-04-15 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050152983-A1 | Directly compressible pharmaceutical composition for the oral administration of CCI-779 | RICTOR, FKBP2, FKBP4 | TDP1 4560/4885EYA2 3126/4885APP 4049/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.